2024-03-012024-12-312024-12-31false08387668CONCIERGE MEDICAL PRACTICE LIMITED2025-09-1786210falseiso4217:GBPxbrli:pure083876682024-02-29083876682024-12-31083876682024-03-012024-12-31083876682023-02-28083876682024-02-29083876682023-03-012024-02-2908387668bus:SmallEntities2024-03-012024-12-3108387668bus:AuditExempt-NoAccountantsReport2024-03-012024-12-3108387668bus:AbridgedAccounts2024-03-012024-12-3108387668bus:PrivateLimitedCompanyLtd2024-03-012024-12-3108387668core:WithinOneYear2024-12-3108387668core:AfterOneYear2024-12-3108387668core:WithinOneYear2024-02-2908387668core:AfterOneYear2024-02-2908387668core:ShareCapital2024-12-3108387668core:SharePremium2024-12-3108387668core:RevaluationReserve2024-12-3108387668core:OtherReservesSubtotal2024-12-3108387668core:RetainedEarningsAccumulatedLosses2024-12-3108387668core:ShareCapital2024-02-2908387668core:SharePremium2024-02-2908387668core:RevaluationReserve2024-02-2908387668core:OtherReservesSubtotal2024-02-2908387668core:RetainedEarningsAccumulatedLosses2024-02-2908387668core:LandBuildings2024-12-3108387668core:PlantMachinery2024-12-3108387668core:Vehicles2024-12-3108387668core:FurnitureFittings2024-12-3108387668core:OfficeEquipment2024-12-3108387668core:NetGoodwill2024-12-3108387668core:IntangibleAssetsOtherThanGoodwill2024-12-3108387668core:ListedExchangeTraded2024-12-3108387668core:UnlistedNon-exchangeTraded2024-12-3108387668core:LandBuildings2024-02-2908387668core:PlantMachinery2024-02-2908387668core:Vehicles2024-02-2908387668core:FurnitureFittings2024-02-2908387668core:OfficeEquipment2024-02-2908387668core:NetGoodwill2024-02-2908387668core:IntangibleAssetsOtherThanGoodwill2024-02-2908387668core:ListedExchangeTraded2024-02-2908387668core:UnlistedNon-exchangeTraded2024-02-2908387668core:LandBuildings2024-03-012024-12-3108387668core:PlantMachinery2024-03-012024-12-3108387668core:Vehicles2024-03-012024-12-3108387668core:FurnitureFittings2024-03-012024-12-3108387668core:OfficeEquipment2024-03-012024-12-3108387668core:NetGoodwill2024-03-012024-12-3108387668core:IntangibleAssetsOtherThanGoodwill2024-03-012024-12-3108387668core:ListedExchangeTraded2024-03-012024-12-3108387668core:UnlistedNon-exchangeTraded2024-03-012024-12-3108387668core:MoreThanFiveYears2024-03-012024-12-3108387668core:Non-currentFinancialInstruments2024-12-3108387668core:Non-currentFinancialInstruments2024-02-2908387668dpl:CostSales2024-03-012024-12-3108387668dpl:DistributionCosts2024-03-012024-12-3108387668core:LandBuildings2024-03-012024-12-3108387668core:PlantMachinery2024-03-012024-12-3108387668core:Vehicles2024-03-012024-12-3108387668core:FurnitureFittings2024-03-012024-12-3108387668core:OfficeEquipment2024-03-012024-12-3108387668dpl:AdministrativeExpenses2024-03-012024-12-3108387668core:NetGoodwill2024-03-012024-12-3108387668core:IntangibleAssetsOtherThanGoodwill2024-03-012024-12-3108387668dpl:GroupUndertakings2024-03-012024-12-3108387668dpl:ParticipatingInterests2024-03-012024-12-3108387668dpl:GroupUndertakingscore:ListedExchangeTraded2024-03-012024-12-3108387668core:ListedExchangeTraded2024-03-012024-12-3108387668dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-03-012024-12-3108387668core:UnlistedNon-exchangeTraded2024-03-012024-12-3108387668dpl:CostSales2023-03-012024-02-2908387668dpl:DistributionCosts2023-03-012024-02-2908387668core:LandBuildings2023-03-012024-02-2908387668core:PlantMachinery2023-03-012024-02-2908387668core:Vehicles2023-03-012024-02-2908387668core:FurnitureFittings2023-03-012024-02-2908387668core:OfficeEquipment2023-03-012024-02-2908387668dpl:AdministrativeExpenses2023-03-012024-02-2908387668core:NetGoodwill2023-03-012024-02-2908387668core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2908387668dpl:GroupUndertakings2023-03-012024-02-2908387668dpl:ParticipatingInterests2023-03-012024-02-2908387668dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2908387668core:ListedExchangeTraded2023-03-012024-02-2908387668dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2908387668core:UnlistedNon-exchangeTraded2023-03-012024-02-2908387668core:NetGoodwill2024-12-3108387668core:IntangibleAssetsOtherThanGoodwill2024-12-3108387668core:LandBuildings2024-12-3108387668core:PlantMachinery2024-12-3108387668core:Vehicles2024-12-3108387668core:FurnitureFittings2024-12-3108387668core:OfficeEquipment2024-12-3108387668core:AfterOneYear2024-12-3108387668core:WithinOneYear2024-12-3108387668core:ListedExchangeTraded2024-12-3108387668core:UnlistedNon-exchangeTraded2024-12-3108387668core:ShareCapital2024-12-3108387668core:SharePremium2024-12-3108387668core:RevaluationReserve2024-12-3108387668core:OtherReservesSubtotal2024-12-3108387668core:RetainedEarningsAccumulatedLosses2024-12-3108387668core:NetGoodwill2024-02-2908387668core:IntangibleAssetsOtherThanGoodwill2024-02-2908387668core:LandBuildings2024-02-2908387668core:PlantMachinery2024-02-2908387668core:Vehicles2024-02-2908387668core:FurnitureFittings2024-02-2908387668core:OfficeEquipment2024-02-2908387668core:AfterOneYear2024-02-2908387668core:WithinOneYear2024-02-2908387668core:ListedExchangeTraded2024-02-2908387668core:UnlistedNon-exchangeTraded2024-02-2908387668core:ShareCapital2024-02-2908387668core:SharePremium2024-02-2908387668core:RevaluationReserve2024-02-2908387668core:OtherReservesSubtotal2024-02-2908387668core:RetainedEarningsAccumulatedLosses2024-02-2908387668core:NetGoodwill2023-02-2808387668core:IntangibleAssetsOtherThanGoodwill2023-02-2808387668core:LandBuildings2023-02-2808387668core:PlantMachinery2023-02-2808387668core:Vehicles2023-02-2808387668core:FurnitureFittings2023-02-2808387668core:OfficeEquipment2023-02-2808387668core:AfterOneYear2023-02-2808387668core:WithinOneYear2023-02-2808387668core:ListedExchangeTraded2023-02-2808387668core:UnlistedNon-exchangeTraded2023-02-2808387668core:ShareCapital2023-02-2808387668core:SharePremium2023-02-2808387668core:RevaluationReserve2023-02-2808387668core:OtherReservesSubtotal2023-02-2808387668core:RetainedEarningsAccumulatedLosses2023-02-2808387668core:AfterOneYear2024-03-012024-12-3108387668core:WithinOneYear2024-03-012024-12-3108387668core:Non-currentFinancialInstrumentscore:CostValuation2024-03-012024-12-3108387668core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-012024-12-3108387668core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-012024-12-3108387668core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-012024-12-3108387668core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-012024-12-3108387668core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-012024-12-3108387668core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-012024-12-3108387668core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-012024-12-3108387668core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-012024-12-3108387668core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3108387668core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3108387668core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3108387668core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3108387668core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3108387668core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3108387668core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3108387668core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3108387668core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3108387668core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2908387668core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2908387668core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2908387668bus:Director12024-03-012024-12-3108387668bus:Director22024-03-012024-12-31

CONCIERGE MEDICAL PRACTICE LIMITED

Registered Number
08387668
(England and Wales)

Unaudited Financial Statements for the Period ended
31 December 2024

CONCIERGE MEDICAL PRACTICE LIMITED
Company Information
for the period from 1 March 2024 to 31 December 2024

Directors

Mr Priyendan Logeswaran
Mr Oliver Rodwell

Registered Address

Unit 4 Lowes Lane Business Park Lowes Lane
Wellesbourne
Warwick
CV35 9RB

Registered Number

08387668 (England and Wales)
CONCIERGE MEDICAL PRACTICE LIMITED
Statement of Financial Position
31 December 2024

Notes

31 Dec 2024

29 Feb 2024

£

£

£

£

Fixed assets
Tangible assets34,5585,379
4,5585,379
Current assets
Stocks-20,000
Debtors142,707103,171
Cash at bank and on hand203,189773,843
345,896897,014
Creditors amounts falling due within one year(129,690)(223,056)
Net current assets (liabilities)216,206673,958
Total assets less current liabilities220,764679,337
Creditors amounts falling due after one year-(72,695)
Net assets220,764606,642
Capital and reserves
Called up share capital117117
Share premium32,58532,585
Profit and loss account188,062573,940
Shareholders' funds220,764606,642
The financial statements were approved and authorised for issue by the Board of Directors on 17 September 2025, and are signed on its behalf by:
Mr Priyendan Logeswaran
Director
Registered Company No. 08387668
CONCIERGE MEDICAL PRACTICE LIMITED
Notes to the Financial Statements
for the period ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Plant and machinery25
Fixtures and fittings25
Office Equipment25
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20242024
Average number of employees during the year2930
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 March 2411,698
Additions698
At 31 December 2412,396
Depreciation and impairment
At 01 March 246,319
Charge for year1,519
At 31 December 247,839
Net book value
At 31 December 244,558
At 29 February 245,379